|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lv W, Yan T, Wang G, Zhao W, Zhang T and
Zhou D: High-intensity focused ultrasound therapy in combination
with gemcitabine for unresectable pancreatic carcinoma. Ther Clin
Risk Manag. 12:687–691. 2016.PubMed/NCBI
|
|
4
|
Khalaf N, El-Serag HB, Abrams HR and
Thrift AP: Burden of pancreatic cancer: From epidemiology to
practice. Clin Gastroenterol Hepatol. 19:876–884. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seufferlein T, Porzner M, Heinemann V,
Tannapfel A, Stuschke M and Uhl W: Ductal pancreatic
adenocarcinoma. Dtsch Arztebl Int. 111:396–402. 2014.PubMed/NCBI
|
|
7
|
Dababou S, Marrocchio C, Rosenberg J,
Bitton R, Pauly KB, Napoli A, Hwang JH and Ghanouni P: A
meta-analysis of palliative treatment of pancreatic cancer with
high intensity focused ultrasound. J Ther Ultrasound. 5:92017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sofuni A, Asai Y, Mukai S, Yamamoto K and
Itoi T: High-intensity focused ultrasound therapy for pancreatic
cancer. J Med Ultrason (2001). May 12–2022.(Epub ahead of print).
View Article : Google Scholar
|
|
9
|
Sapareto SA and Dewey WC: Thermal dose
determination in cancer therapy. Int J Radiat Oncol Biol Phys.
10:787–800. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dewhirst MW, Viglianti BL, Lora-Michiels
M, Hanson M and Hoopes PJ: Basic principles of thermal dosimetry
and thermal thresholds for tissue damage from hyperthermia. Int J
Hyperthermia. 19:267–294. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu F, Hu Z, Qiu L, Hui C, Li C, Zhong P
and Zhang J: Boosting high-intensity focused ultrasound-induced
anti-tumor immunity using a sparse-scan strategy that can more
effectively promote dendritic cell maturation. J Transl Med.
8:72010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang K, Zhu H, Meng Z, Chen Z, Lin J, Shen
Y and Gao H: Safety evaluation of high-intensity focused ultrasound
in patients with pancreatic cancer. Onkologie. 36:88–92.
2013.PubMed/NCBI
|
|
13
|
Sofuni A, Asai Y, Tsuchiya T, Ishii K,
Tanaka R, Tonozuka R, Honjo M, Mukai S, Nagai K, Yamamoto K, et al:
Novel therapeutic method for unresectable pancreatic cancer-the
impact of the long-term research in therapeutic effect of
high-intensity focused ultrasound (HIFU) therapy. Curr Oncol.
28:4845–4861. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duan F, Su XL, Wei ZX, Kong DW, Huang TY
and Wang S: Efficacy of computed tomography-guided implantation of
125I seeds in the treatment of refractory malignant tumors
accompanied with cancer pain and its influence on tumor markers in
the serum. Eur Rev Med Pharmacol Sci. 22:1595–1601. 2018.PubMed/NCBI
|
|
15
|
Fan T and Zhou JY: Computed
tomography-guided 125I radioactive seed implantation therapy for
pancreatic cancer pain. J Coll Physicians Surg Pak. 30:364–368.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mor V, Laliberte L, Morris JN and Wiemann
M: The karnofsky performance status scale. An examination of its
reliability and validity in a research setting. Cancer.
53:2002–2007. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Niu H, Zhang X, Wang B, Zhou Z, Wang J and
Xu Z: The clinical utility of image-guided iodine-125 seed in
patients with unresectable pancreatic cancer. Tumour Biol.
37:2219–2223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Borasi G, Russo G, Alongi F, Nahum A,
Candiano GC, Stefano A, Gilardi MC and Messa C: High-intensity
focused ultrasound plus concomitant radiotherapy: A new weapon in
oncology? J Ther Ultrasound. 1:62013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li YJ, Huang GL, Sun XL, Zhao XC and Li
ZG: The combination therapy of high-intensity focused ultrasound
with radiotherapy in locally advanced pancreatic carcinoma. World J
Surg Oncol. 14:602016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Minniti G, Goldsmith C and Brada M:
Radiotherapy. Handb Clin Neurol. 104:215–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
DeNardo GL and DeNardo SJ: Update: Turning
the heat on cancer. Cancer Biother Radiopharm. 23:671–680.
2008.PubMed/NCBI
|
|
22
|
Kakar S, Pawlik TM, Allen PJ and Vauthey
JN: Exocrine pancreas. Pancreatic adenocarcinoma. AJCC cancer
staging manual. 8th ed. New York: Springer-Verlag; 2016
|
|
23
|
Marinova M, Rauch M, Mücke M, Rolke R,
Gonzalez-Carmona MA, Henseler J, Cuhls H, Radbruch L, Strassburg
CP, Zhang L, et al: High-intensity focused ultrasound (HIFU) for
pancreatic carcinoma: Evaluation of feasibility, reduction of
tumour volume and pain intensity. Eur Radiol. 26:4047–4056. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao H, Yang G, Wang D, Yu X, Zhang Y, Zhu
J, Ji Y, Zhong B, Zhao W, Yang Z and Aziz F: Concurrent gemcitabine
and high-intensity focused ultrasound therapy in patients with
locally advanced pancreatic cancer. Anticancer Drugs. 21:447–452.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Jiang Y, Li J, Tian S, Ran W and
Xiu D: Intraoperative ultrasound-guided iodine-125 seed
implantation for unresectable pancreatic carcinoma. J Exp Clin
Cancer Res. 28:882009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Y: High-intensity focused ultrasound
treatment for advanced pancreatic cancer. Gastroenterol Res Pract.
2014:2053252014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McCaffery M and Beebe A: Pain: Clinical
manual for nursing practice. Mosby, St Louis, MO: 1989
|
|
28
|
Liu YJ, Zhu GP and Guan XY: Comparison of
the NCI-CTCAE version 4.0 and version 3.0 in assessing
chemoradiation-induced oral mucositis for locally advanced
nasopharyngeal carcinoma. Oral Oncol. 48:554–559. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kolbeinsson HM, Chandana S, Wright GP and
Chung M: Pancreatic cancer: A review of current treatment and novel
therapies. J Invest Surg. 36:21298842023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Torphy RJ, Fujiwara Y and Schulick RD:
Pancreatic cancer treatment: Better, but a long way to go. Surg
Today. 50:1117–1125. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vidal-Jove J, Perich E and Del Castillo
MA: Ultrasound guided high intensity focused ultrasound for
malignant tumors: The Spanish experience of survival advantage in
stage III and IV pancreatic cancer. Ultrason Sonochem. 27:703–706.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li PZ, Zhu SH, He W, Zhu LY, Liu SP, Liu
Y, Wang GH and Ye F: High-intensity focused ultrasound treatment
for patients with unresectable pancreatic cancer. Hepatobiliary
Pancreat Dis Int. 11:655–660. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang K, Chen Z, Meng Z, Lin J, Zhou Z,
Wang P, Chen L and Liu L: Analgesic effect of high intensity
focused ultrasound therapy for unresectable pancreatic cancer. Int
J Hyperthermia. 27:101–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao HF, Wang K, Meng ZQ, Chen Z, Lin JH,
Zhou ZH, Wang P, Shi WD and Sheng YH: High intensity focused
ultrasound treatment for patients with local advanced pancreatic
cancer. Hepatogastroenterology. 60:1906–1910. 2013.PubMed/NCBI
|
|
35
|
Peretz T, Nori D, Hilaris B, Manolatos S,
Linares L, Harrison L, Anderson LL, Fuks Z and Brennan MF:
Treatment of primary unresectable carcinoma of the pancreas with
I-125 implantation. Int J Radiat Oncol Biol Phys. 17:931–935. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gai B and Zhang F: Chinese expert
consensus on radioactive 125I seeds interstitial implantation
brachytherapy for pancreatic cancer. J Cancer Res Ther.
14:1455–1462. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ning Z, Xie J, Chen Q, Zhang C, Xu L, Song
L and Meng Z: HIFU is safe, effective, and feasible in pancreatic
cancer patients: A monocentric retrospective study among 523
patients. Onco Targets Ther. 12:1021–1029. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li CG, Zhou ZP, Jia YZ, Tan XL and Song
YY: Radioactive 125I seed implantation for locally advanced
pancreatic cancer: A retrospective analysis of 50 cases. World J
Clin Cases. 8:3743–3750. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang H, Wang J, Jiang Y, Li J, Tian S, Ran
W, Xiu D and Gao Y: The investigation of 125I seed implantation as
a salvage modality for unresectable pancreatic carcinoma. J Exp
Clin Cancer Res. 32:1062013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jin Z, Du Y, Li Z, Jiang Y, Chen J and Liu
Y: Endoscopic ultrasonography-guided interstitial implantation of
iodine 125-seeds combined with chemotherapy in the treatment of
unresectable pancreatic carcinoma: a prospective pilot study.
Endoscopy. 40:314–320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhongmin W, Yu L, Fenju L, Kemin C and
Gang H: Clinical efficacy of CT-guided iodine-125 seed implantation
therapy in patients with advanced pancreatic cancer. Eur Radiol.
20:1786–1791. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wrenn SP, Dicker SM, Small EF, Dan NR,
Mleczko M, Schmitz G and Lewin PA: Bursting bubbles and bilayers.
Theranostics. 2:1140–1159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rosenschein U, Furman V, Kerner E, Fabian
I, Bernheim J and Eshel Y: Ultrasound imaging-guided noninvasive
ultrasound thrombolysis: preclinical results. Circulation.
102:238–245. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sofuni A, Moriyasu F, Sano T, Yamada K,
Itokawa F, Tsuchiya T, Tsuji S, Kurihara T, Ishii K and Itoi T: The
current potential of high-intensity focused ultrasound for
pancreatic carcinoma. J Hepatobiliary Pancreat Sci. 18:295–303.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Marinova M, Feradova H, Gonzalez-Carmona
MA, Conrad R, Tonguc T, Thudium M, Becher MU, Kun Z, Gorchev G,
Tomov S, et al: Improving quality of life in pancreatic cancer
patients following high-intensity focused ultrasound (HIFU) in two
European centers. Eur Radiol. 31:5818–5829. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ning ZY, Cheng CS, Xie J, Chen QW, Xu LT,
Zhuang LP, Zhang CY, Song LB, Shi WD, Zhu XY, et al: A
retrospective analysis of survival factors of high intensity
focused ultrasound (HIFU) treatment for unresectable pancreatic
cancer. Discov Med. 21:435–445. 2016.PubMed/NCBI
|
|
47
|
Yang SY, Liu F, Liu Y, Xia FF and Fu YF:
Stent insertion with high-intensity focused ultrasound ablation for
distal biliary obstruction secondary to pancreatic carcinoma.
Medicine (Baltimore). 99:e190992020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
